Your browser doesn't support javascript.
loading
The Infectious Diseases Society of America's 10 × '20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × '20 a Possibility?
Talbot, George H; Jezek, Amanda; Murray, Barbara E; Jones, Ronald N; Ebright, Richard H; Nau, Gerard J; Rodvold, Keith A; Newland, Jason G; Boucher, Helen W.
Afiliação
  • Talbot GH; Talbot Advisors LLC, Anna Maria, Florida.
  • Jezek A; Infectious Diseases Society of America, Arlington, Virginia.
  • Murray BE; Division of Infectious Diseases, McGovern Medical School at the University of Texas Health Science Center, Houston.
  • Jones RN; JMI Laboratories, North Liberty, Iowa.
  • Ebright RH; Department of Chemistry and Waksman Institute, Rutgers University, Piscataway, New Jersey.
  • Nau GJ; Division of Infectious Diseases, Alpert Medical School at Brown University, Providence, Rhode Island.
  • Rodvold KA; College of Pharmacy, University of Illinois at Chicago.
  • Newland JG; Division of Pediatric Infectious Diseases, Washington University, St. Louis, Missouri.
  • Boucher HW; Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts.
Clin Infect Dis ; 69(1): 1-11, 2019 06 18.
Article em En | MEDLINE | ID: mdl-30715222
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: United States Food and Drug Administration / Aprovação de Drogas / Antibacterianos País/Região como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: United States Food and Drug Administration / Aprovação de Drogas / Antibacterianos País/Região como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article